RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bavarian Nordic A/S Stock

Bavarian Nordic A/S Dividend 2024

Bavarian Nordic A/S Dividend

0 DKK

Bavarian Nordic A/S Dividend yield

Ticker

BAVA.CO

ISIN

DK0015998017

WKN

917165

How much dividend does Bavarian Nordic A/S 2024 pay?

According to the latest status from July 2024, Bavarian Nordic A/S paid a total of 0 DKK per share in dividends within the last 12 months. With the current Bavarian Nordic A/S price of 185.95 DKK, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Bavarian Nordic A/S Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Bavarian Nordic A/S Dividend Safe?

Bavarian Nordic A/S has been increasing the dividend for 0 years.

Over the past 10 years, Bavarian Nordic A/S has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Bavarian Nordic A/S's Dividend Distributions

Bavarian Nordic A/S’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Bavarian Nordic A/S's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Bavarian Nordic A/S's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Bavarian Nordic A/S’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Bavarian Nordic A/S Aktienanalyse

What does Bavarian Nordic A/S do?

Bavarian Nordic A/S is a biopharmaceutical company based in Denmark, specializing in the development and production of vaccines. The company was established in 1994 as a spin-off from the University of Copenhagen and has been listed on the Copenhagen stock exchange since 1998. The company's history began with an innovation developed by Professor Peter Andersen at the University of Copenhagen - the Viruslike Particles (VLP) technology. This technology serves as the basis for the production of vaccines against severe infectious diseases such as influenza, RSV, or HPV. Bavarian Nordic utilizes this technology to generate effective immune responses without using live pathogens. The company's business model is focused on two areas: the commercial vaccine sector and the biodefense products sector. The commercial sector includes the development and production of vaccines for cancer (such as prostate cancer or breast cancer) as well as infectious diseases like RSV. The biodefense products sector concentrates on protection against biological attacks, with the company manufacturing vaccines against bioweapons such as anthrax or smallpox for governmental institutions. Bavarian Nordic is divided into various business divisions. One of these is the commercial vaccines department, which develops and produces vaccines for the commercial market, particularly for cancer indications. The company also has a biodefense products department, which safeguards governmental institutions and organizations against bioterrorist attacks and other threats posed by biological weapons. This department focuses on the development and production of vaccines against smallpox, anthrax, and Ebola virus. Bavarian Nordic offers a wide range of products. The commercial vaccine Prostvac against prostate cancer is the company's flagship product. Other vaccines that have been developed or are still in development include vaccines against breast cancer, influenza, RSV, and lung cancer. The biodefense products encompass vaccines against smallpox, anthrax, and Ebola virus, as well as preclinical development programs for additional biological attacks. The company has also signed cooperation agreements with other companies to accelerate the research and development of new products. These include collaborations with Bristol Myers Squibb and Janssen Pharmaceutica for the development of cancer vaccines, as well as with the British Ministry of Defence for the development of vaccines against anthrax. Overall, Bavarian Nordic A/S caters to a broad range of interests and business sectors. The company focuses on the development and production of vaccines for both commercial and governmental institutions, aiming to enhance protection against biological threats and infectious diseases. Thanks to its innovative VLP technology, the company is a key player in the field of vaccine development and offers a wide range of products. Bavarian Nordic A/S is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Bavarian Nordic A/S stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about Bavarian Nordic A/S stock

How much dividend does Bavarian Nordic A/S pay?

Over the past 12 months, Bavarian Nordic A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bavarian Nordic A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Bavarian Nordic A/S?

The current dividend yield of Bavarian Nordic A/S is .

When does Bavarian Nordic A/S pay dividends?

Bavarian Nordic A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bavarian Nordic A/S?

Bavarian Nordic A/S paid dividends every year for the past 0 years.

What is the dividend of Bavarian Nordic A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bavarian Nordic A/S located?

Bavarian Nordic A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bavarian Nordic A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bavarian Nordic A/S from 7/29/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did Bavarian Nordic A/S pay the last dividend?

The last dividend was paid out on 7/29/2024.

What was the dividend of Bavarian Nordic A/S in the year 2023?

In the year 2023, Bavarian Nordic A/S distributed 0 DKK as dividends.

In which currency does Bavarian Nordic A/S pay out the dividend?

The dividends of Bavarian Nordic A/S are distributed in DKK.

Andere Kennzahlen von Bavarian Nordic A/S

Our stock analysis for Bavarian Nordic A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bavarian Nordic A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.